Abstract
Purpose
We aimed to examine the effect of high-fat diet (HFD) on prostate cancer (PCa) development and progression and to investigate whether metformin would postpone PCa development and progression promoted by HFD.
Methods
TRAMP mice were randomly divided into three groups: normal diet group, HFD group and metformin-HFD (Met-HFD) group. Mortality rate and tumor formation rate were examined. TRAMP mice were sacrificed and sampled on the 20th, 24th, and 28th week, respectively. Serum levels of insulin and IGF-1 were tested by ELISA. Prostate tissue of TRAMP mice was used for HE staining.
Results
A total of 17 deaths of TRAMP mice were observed, including 3 (10 %) from the normal diet group, 10 (33.33 %) from the HFD group, and 4 (13.33 %) from Met-HFD group. The mortality rate of TRAMP mice from HFD group was significantly higher than that of normal diet group (P = 0.028), and metformin could moderately decrease the mortality rate by 60.01 % (P = 0.067). Tumor formation rates were not significantly different among the three groups. Levels of glucose, insulin, and IGF-1 tended to increase with TRAMP mice’s age in HFD group. TRAMP mice from HFD group had higher serum insulin and IGF-1 levels. A moderate decrease in IGF-1 was also seen in Met-HFD group.
Conclusions
HFD could promote TRAMP mouse PCa development and progression and metformin had moderate effect of reducing PCa mortality rate with a decrease in serum IGF-1 level.
Similar content being viewed by others
References
Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29
Sim HG, Cheng CW (2005) Changing demography of prostate cancer in Asia. Eur J Cancer 41:834–845
Fleshner N, Bagnell PS, Klotz L, Venkateswaran V (2004) Dietary fat and prostate cancer. J Urol 171:S19–S24
Lophatananon A, Archer J, Easton D et al (2010) Dietary fat and early-onset prostate cancer risk. Br J Nutr 103:1375–1380
Kristal AR, Cohen JH, Qu P, Stanford JL (2002) Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 11:719–725
Deneo-Pellegrini H, De Stefani E, Ronco A, Mendilaharsu M (1999) Foods, nutrients and prostate cancer: a case-control study in Uruguay. Br J Cancer 80:591–597
Andersson SO, Wolk A, Bergstrom R et al (1996) Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer 68:716–722
Pollard M, Luckert PH (1985) Promotional effects of testosterone and dietary fat on prostate carcinogenesis in genetically susceptible rats. Prostate 6:1–5
Pollard M, Luckert PH (1986) Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats. Cancer Lett 32:223–227
Tamano S, Rehm S, Waalkes MP, Ward JM (1996) High incidence and histogenesis of seminal vesicle adenocarcinoma and lower incidence of prostate carcinomas in the Lobund-Wistar prostate cancer rat model using N-nitrosomethylurea and testosterone. Vet Pathol 33:557–567
Carroll KK, Noble RL (1987) Dietary fat in relation to hormonal induction of mammary and prostatic carcinoma in Nb rats. Carcinogenesis 8:851–853
Pour PM, Groot K, Kazakoff K, Anderson K, Schally AV (1991) Effects of high-fat diet on the patterns of prostatic cancer induced in rats by N-nitrosobis(2-oxopropyl)amine and testosterone. Cancer Res 51:4757–4761
Panchal SK, Poudyal H, Iyer A et al (2011) High-carbohydrate high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol 57:51–64
Gallou-Kabani C, Vige A, Gross MS et al (2007) C57BL/6 J and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity (Silver Spring) 15:1996–2005
Ben Sahra I, Laurent K, Loubat A et al (2008) The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene 27:3576–3586
Zhou G, Myers R, Li Y et al (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167–1174
Bodmer WF (2000) Prostate cancer 2000. Prostate Cancer Prostatic Dis 3:218–223
Gingrich JR, Greenberg NM (1996) A transgenic mouse prostate cancer model. Toxicol Pathol 24:502–504
Gingrich JR, Barrios RJ, Morton RA et al (1996) Metastatic prostate cancer in a transgenic mouse. Cancer Res 56:4096–4102
Greenberg NM, DeMayo F, Finegold MJ et al (1995) Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92:3439–3443
Park SH, Chang SN, Baek MW et al (2013) Effects of dietary high fat on prostate intraepithelial neoplasia in TRAMP mice. Lab Anim Res 29:39–47
Yki-Jarvinen H, K. Nikkila and S Makimattila (1999), Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus. Drugs 58(Suppl 1): 53–54; discussion 75–82
Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD (1995) Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 87:1456–1462
Saw CL, Wu TY, Paredes-Gonzalez X, Khor TO, Pung D, Kong AN (2011) Pharmacodynamics of fish oil: protective effects against prostate cancer in TRAMP mice fed with a high fat western diet. Asian Pac J Cancer Prev 12:3331–3334
Patel P, Abate N (2013) Body fat distribution and insulin resistance. Nutrients 5:2019–2027
Nasteska D, Harada N, Suzuki K, et al. (2014), Chronic reduction of GIP secretion alleviates obesity and insulin resistance under high fat diet condition. Diabetes 63:2332–2343
Kaklamani VG, Linos A, Kaklamani E, Markaki I, Koumantaki Y, Mantzoros CS (1999) Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults. J Clin Oncol 17:3291–3298
Freedland SJ, Mavropoulos J, Wang A et al (2008) Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate 68:11–19
Venkateswaran V, Haddad AQ, Fleshner NE et al (2007) Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts. J Natl Cancer Inst 99:1793–1800
Conflict of interest
All authors declare there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xu, H., Hu, Mb., Bai, Pd. et al. Will metformin postpone high-fat diet promotion of TRAMP mouse prostate cancer development and progression?. Int Urol Nephrol 46, 2327–2334 (2014). https://doi.org/10.1007/s11255-014-0823-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-014-0823-x